ESR1 and cancer: In contrast to the findings for all-cause mortality however, current HT was found to greatly increase the risk of cancer-specific mortality for women homozygous TT or AA for ESR1 rs2234693 and rs9340799, respectively, and for those with the GG genotype of ESR2 rs1271572.